APUS Stock Analysis: Buy, Sell, or Hold?
APUS - Apimeds Pharmaceuticals US, Inc.
$4.85
-0.30 (-5.83%)
▼
5d:
-22.89%
30d:
+438.89%
90d:
+177.14%
WAIT
LOW Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 18, 2026
14d
Get Alerted When APUS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: APUS is down 22.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: APUS is down 22.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: APUS is currently trading at $4.85, which is considered extended relative to its 30-day fair value range of $-0.20 to $4.34.
Technical Outlook: Technically, APUS is showing sideways momentum. Immediate support is located at $0.61, while resistance sits at $8.28. Short-term momentum is weak, with the stock down 5.8% recently.
Market Sentiment: APUS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, APUS is showing sideways momentum. Immediate support is located at $0.61, while resistance sits at $8.28. Short-term momentum is weak, with the stock down 5.8% recently.
Market Sentiment: APUS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$-0.20 -
$4.34
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
41.2%
All Signals
- BEARISH: Price significantly overextended (+11.8% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.8%)
Trading Range Analysis
30-Day Trading Range
$-0.20 -
$4.34
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.61
Resistance Level
$8.28
Current Trend
Sideways
Technical data as of
Aug 3, 2026
Fundamental Context
Share & Embed Analysis
Last updated: August 03, 2026 5:18 PM ET
Data refreshes hourly during market hours. Next update: 6:18 PM
Data refreshes hourly during market hours. Next update: 6:18 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is APUS showing a specific setup today?
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$211 | 60 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$112 | 52 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$663 | 48 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$113 | 45 HOLD |
|
AVDL
Avadel Pharmaceuticals P… |
STRONG BUY
8 analysts |
$21 | 62 BUY |